Trial Profile
Phase II Study Of BBR 3464 As Treatment In Patients With Sensitive Or Refractory Small Cell Lung Cancer After One Prior Chemotherapy Regimen
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2005
Price :
$35
*
At a glance
- Drugs BBR 3464 (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 19 Sep 2005 New trial record.